1-(4-methoxyphenyl)-2-(3,4,5-trimethoxyphenyl)ethene has been researched along with benzofurans in 1 studies
Studies (1-(4-methoxyphenyl)-2-(3,4,5-trimethoxyphenyl)ethene) | Trials (1-(4-methoxyphenyl)-2-(3,4,5-trimethoxyphenyl)ethene) | Recent Studies (post-2010) (1-(4-methoxyphenyl)-2-(3,4,5-trimethoxyphenyl)ethene) | Studies (benzofurans) | Trials (benzofurans) | Recent Studies (post-2010) (benzofurans) |
---|---|---|---|---|---|
30 | 0 | 23 | 13,293 | 451 | 4,970 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Crooks, PA; Penthala, NR; Thakkar, S | 1 |
1 other study(ies) available for 1-(4-methoxyphenyl)-2-(3,4,5-trimethoxyphenyl)ethene and benzofurans
Article | Year |
---|---|
Heteroaromatic analogs of the resveratrol analog DMU-212 as potent anti-cancer agents.
Topics: Antineoplastic Agents; Benzofurans; Benzothiazoles; Binding Sites; Cell Line, Tumor; Cell Survival; Colchicine; Drug Screening Assays, Antitumor; Humans; Molecular Docking Simulation; Protein Structure, Tertiary; Resveratrol; Stilbenes; Thiophenes; Tubulin | 2015 |